THE DEAL, AT A GLANCE
From the announcementGenesis Therapeutics
01Who is involvedBacked by a16z BioFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedGenesis Therapeutics raised $200M Series BFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersGenesis Therapeutics' $200M Series B is a top-quartile Healthcare & Life Sciences financing that signals continued capital concentration around AI drug discovery using…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Genesis Therapeutics · Financing Record
Explore source-linked visual explanations for Genesis Therapeutics. Unsupported claims are withheld while source review continues.
Record 1214 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →